Cargando…

Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis

BACKGROUND: Infection with human papillomavirus (HPV) is necessary for the development of cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies, such as head and neck cancers, is less well characterised. This study aimed to address key information gaps by conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Abogunrin, Seye, Di Tanna, Gian Luca, Keeping, Sam, Carroll, Stuart, Iheanacho, Ike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320477/
https://www.ncbi.nlm.nih.gov/pubmed/25515630
http://dx.doi.org/10.1186/1471-2407-14-968
_version_ 1782356122170032128
author Abogunrin, Seye
Di Tanna, Gian Luca
Keeping, Sam
Carroll, Stuart
Iheanacho, Ike
author_facet Abogunrin, Seye
Di Tanna, Gian Luca
Keeping, Sam
Carroll, Stuart
Iheanacho, Ike
author_sort Abogunrin, Seye
collection PubMed
description BACKGROUND: Infection with human papillomavirus (HPV) is necessary for the development of cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies, such as head and neck cancers, is less well characterised. This study aimed to address key information gaps by conducting a systematic review and meta-analysis of the prevalence of HPV infection in head and neck cancers, focusing on data for European populations. METHODS: MEDLINE, Embase and grey literature sources were systematically searched for primary studies that were published in English between July 2002 and July 2012, and which reported on the prevalence of HPV infection in head and neck cancers in European populations. Studies on non-European populations, those not published in English, and those assessing patients co-infected with human immunodeficiency virus were excluded. Eligible studies were combined in a meta-analysis. In addition, the potential statistical association between the head and neck cancers and certain HPV types was investigated. RESULTS: Thirty-nine publications met the inclusion criteria. The prevalence of HPV of any type in 3,649 patients with head and neck cancers was 40.0% (95% confidence interval, 34.6% to 45.5%), and was highest in tonsillar cancer (66.4%) and lowest in pharyngeal (15.3%) and tongue (25.7%) cancers. There were no statistically significant associations between the HPV types analysed and the geographical setting, type of sample analysed or type of primer used to analyse samples in head and neck cancers. CONCLUSIONS: The prevalence of HPV infection in European patients with head and neck cancers is high but varies between the different anatomical sites of these malignancies. There appears to be no association between HPV type and geographical setting, type of samples analysed or type of primer used to analyse samples in such cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-968) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4320477
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43204772015-02-08 Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis Abogunrin, Seye Di Tanna, Gian Luca Keeping, Sam Carroll, Stuart Iheanacho, Ike BMC Cancer Research Article BACKGROUND: Infection with human papillomavirus (HPV) is necessary for the development of cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies, such as head and neck cancers, is less well characterised. This study aimed to address key information gaps by conducting a systematic review and meta-analysis of the prevalence of HPV infection in head and neck cancers, focusing on data for European populations. METHODS: MEDLINE, Embase and grey literature sources were systematically searched for primary studies that were published in English between July 2002 and July 2012, and which reported on the prevalence of HPV infection in head and neck cancers in European populations. Studies on non-European populations, those not published in English, and those assessing patients co-infected with human immunodeficiency virus were excluded. Eligible studies were combined in a meta-analysis. In addition, the potential statistical association between the head and neck cancers and certain HPV types was investigated. RESULTS: Thirty-nine publications met the inclusion criteria. The prevalence of HPV of any type in 3,649 patients with head and neck cancers was 40.0% (95% confidence interval, 34.6% to 45.5%), and was highest in tonsillar cancer (66.4%) and lowest in pharyngeal (15.3%) and tongue (25.7%) cancers. There were no statistically significant associations between the HPV types analysed and the geographical setting, type of sample analysed or type of primer used to analyse samples in head and neck cancers. CONCLUSIONS: The prevalence of HPV infection in European patients with head and neck cancers is high but varies between the different anatomical sites of these malignancies. There appears to be no association between HPV type and geographical setting, type of samples analysed or type of primer used to analyse samples in such cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-968) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-17 /pmc/articles/PMC4320477/ /pubmed/25515630 http://dx.doi.org/10.1186/1471-2407-14-968 Text en © Abogunrin et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Abogunrin, Seye
Di Tanna, Gian Luca
Keeping, Sam
Carroll, Stuart
Iheanacho, Ike
Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
title Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
title_full Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
title_fullStr Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
title_full_unstemmed Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
title_short Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
title_sort prevalence of human papillomavirus in head and neck cancers in european populations: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320477/
https://www.ncbi.nlm.nih.gov/pubmed/25515630
http://dx.doi.org/10.1186/1471-2407-14-968
work_keys_str_mv AT abogunrinseye prevalenceofhumanpapillomavirusinheadandneckcancersineuropeanpopulationsametaanalysis
AT ditannagianluca prevalenceofhumanpapillomavirusinheadandneckcancersineuropeanpopulationsametaanalysis
AT keepingsam prevalenceofhumanpapillomavirusinheadandneckcancersineuropeanpopulationsametaanalysis
AT carrollstuart prevalenceofhumanpapillomavirusinheadandneckcancersineuropeanpopulationsametaanalysis
AT iheanachoike prevalenceofhumanpapillomavirusinheadandneckcancersineuropeanpopulationsametaanalysis